Defying the Unfavorable Risk: The Efficacy of LDR Brachytherapy Monotherapy in Gleason 7 Prostate Cancer: A 16-Year Single-Center Retrospective Study.

Rabaça C, Roda D, Vieira G, Pereira B, Godinho R, Lourenço M, Pereira JA, Regencio M, Macedo S, Oliveira RC, Sismeiro A, Pinto AM

Open source

DOI
10.3390/cancers18162546
Published
2026 Aug 7
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18162546,
  title = {Defying the Unfavorable Risk: The Efficacy of LDR Brachytherapy Monotherapy in Gleason 7 Prostate Cancer: A 16-Year Single-Center Retrospective Study.},
  author = {Rabaça C and Roda D and Vieira G and Pereira B and Godinho R and Lourenço M and Pereira JA and Regencio M and Macedo S and Oliveira RC and Sismeiro A and Pinto AM},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18162546},
  url = {https://doi.org/10.3390/cancers18162546}
}

RIS

TY  - JOUR
TI  - Defying the Unfavorable Risk: The Efficacy of LDR Brachytherapy Monotherapy in Gleason 7 Prostate Cancer: A 16-Year Single-Center Retrospective Study.
AU  - Rabaça C
AU  - Roda D
AU  - Vieira G
AU  - Pereira B
AU  - Godinho R
AU  - Lourenço M
AU  - Pereira JA
AU  - Regencio M
AU  - Macedo S
AU  - Oliveira RC
AU  - Sismeiro A
AU  - Pinto AM
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18162546
UR  - https://doi.org/10.3390/cancers18162546
ER  - 

APA

C, R., D, R., G, V., B, P., R, G., M, L., JA, P., M, R., S, M., RC, O., A, S., & AM, P. (2026). Defying the Unfavorable Risk: The Efficacy of LDR Brachytherapy Monotherapy in Gleason 7 Prostate Cancer: A 16-Year Single-Center Retrospective Study.. Cancers. https://doi.org/10.3390/cancers18162546

Source records